Thomas L. Rudge Jr. ,Karen A. Sankovich,Nancy A. Niemuth,Michael S. Anderson,Christopher S. Badorrek,Nick D. Skomrock,Chris M. Cirimotich,Carol L. Sabourin
Plos One April 18, 2019
“The need for an efficacious vaccine against highly pathogenic filoviruses was reinforced by the recent and devastating 2014–2016 outbreak of Ebola virus (EBOV) disease in Guinea, Sierra Leone, and Liberia that resulted in more than 10,000 casualties. …The negative control (NC) serum (0 ELISA units/mL, Lot Number BMI530) was generated by pooling equivalent volumes of 23 individual naïve human serum samples purchased from Innovative Research (Novi, MI)…”
Related products available from Innovative Research also include:
The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!